In the past decade, a large body of literature has reported that CDK1 is highly expressed in hepatocellular carcinoma, lung cancer, breast cancer, thyroid cancer, colorectal cancer, prostate cancer and other malignant tumors [45,46,47,48,49]. This evidence concerns the gene CDK1 and lung carcinoma.